BLSIF (Britannia Life Sciences) 10-Year Share Buyback Ratio: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Britannia Life Sciences 10-Year Share Buyback Ratio?

Britannia Life Sciences BLSIF 10-Year Share Buyback Ratio is 0.00 as of Mar. 2026. The stock has 5 warning signs investors should review. Among 667 Biotechnology companies, Britannia Life Sciences ranks worse than 149924.89% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Britannia Life Sciences's current 10-Year Share Buyback Ratio was 0.00%.

BLSIF's 10-Year Share Buyback Ratio is not ranked *
in the Biotechnology industry.
Industry Median: -11.9
* Ranked among companies with meaningful 10-Year Share Buyback Ratio only.

Britannia Life Sciences (OTCPK:BLSIF) 10-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Britannia Life Sciences 10-Year Share Buyback Ratio Related Terms

BLSIF vs VRTX, REGN, MRNA: 10-Year Share Buyback Ratio Comparison

For the Biotechnology subindustry, Britannia Life Sciences's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Britannia Life Sciences 10-Year Share Buyback Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Britannia Life Sciences's 10-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Britannia Life Sciences's 10-Year Share Buyback Ratio falls into.


Britannia Life Sciences 10-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 10-Year Share Buyback Ratio of 0.00 mean?
Britannia Life Sciences (BLSIF) has a 10-Year Share Buyback Ratio of 0.00 as of Mar. 2026. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Britannia Life Sciences and its competitors. According to the industry distribution chart, Britannia Life Sciences ranks #999999 out of 667 companies in the Biotechnology industry.
Is Britannia Life Sciences' 10-Year Share Buyback Ratio too high?
Britannia Life Sciences' current 10-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Britannia Life Sciences ranks #999999 out of 667 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Britannia Life Sciences' 10-Year Share Buyback Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Britannia Life Sciences ranks #999999 out of 667 companies for 10-Year Share Buyback Ratio. This places Britannia Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Share Buyback Ratio for a Biotechnology company?
A good 10-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 10-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Share Buyback Ratio mean?
A high 10-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Britannia Life Sciences and its competitors. Britannia Life Sciences's current 10-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Britannia Life Sciences stock overvalued right now?
Britannia Life Sciences (BLSIF) has a current 10-Year Share Buyback Ratio of 0.00. The current 10-Year Share Buyback Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Share Buyback Ratio calculated?
10-Year Share Buyback Ratio is calculated from a company's financial statements. For Britannia Life Sciences (BLSIF), the current 10-Year Share Buyback Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Britannia Life Sciences Business Description

Other Exchanges BLAB:Canada
Address 120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc provides product testing, safety assessment, and manufacturing services to the cosmetic and consumer packaged goods industries in the United Kingdom and globally.